In Vitro and in Vivo Neuroprotective Effects of CJun N-terminal Kinase Inhibitors on Retinal Ganglion Cells

Overview

Journal Mol Neurodegener

Publisher Biomed Central

Specialties Molecular Biology
Neurology

Date 2016 Apr 22

PMID 27098079

Citations 28

Authors

Byung-Jin Kim

Sean M Silverman

Yang Liu

Robert J Wordinger

Iok-Hou Pang

Abbot F Clark

Affiliations

Soon will be listed here.

Abstract

Background: The c-Jun N-terminal kinase (JNK) signaling pathway plays an important role in neuronal pathophysiology. Using JNK inhibitors, we examined involvement of the JNK pathway in cultured rat retinal ganglion cell (RGC) death and in mouse retinal ischemia/reperfusion (I/R) injury of the visual axis. The in vitro effects of JNK inhibitors were evaluated in cultured adult rat retinal cells enriched in RGCs. Retinal I/R was induced in C57BL/6J mice through elevation of intraocular pressure to 120 mmHg for 60 min followed by reperfusion. SP600125 was administered intraperitoneally once daily for 28 days. Phosphorylation of JNK and c-Jun in the retina was examined by immunoblotting and immunohistochemistry. The thickness of retinal layers and cell numbers in the ganglion cell layer (GCL) were examined using H&E stained retinal cross sections and spectral domain optical coherence tomography (SD-OCT). Retinal function was measured by scotopic flash electroretinography (ERG). Volumetric measurement of the superior colliculus (SC) as well as VGLUT2 and PSD95 expression were studied.

Results: JNK inhibitors SP600125 and TAT-JNK-III, dose-dependently and significantly (p < 0.05) protected against glutamate excitotoxicity and trophic factor withdrawal induced RGC death in culture. In the I/R model, phosphorylation of JNK (pJNK) in the retina was significantly (p < 0.05) increased after injury. I/R injury significantly (p < 0.05) decreased the thickness of retinal layers, including the whole retina, inner plexiform layer, and inner nuclear layer and cell numbers in the GCL. Administration of SP600125 for 28 days protected against all these degenerative morphological changes (p < 0.05). In addition, SP600125 significantly (p < 0.05) protected against I/R-induced reduction in scotopic ERG b-wave amplitude at 3, 7, 14, 21 and 28 days after injury. SP600125 also protected against the I/R-induced losses in volume and levels of synaptic markers in the SC. Moreover, the protective effects of SP600125 in the retina and SC were also detected even with only 7 days (Days 1-7 after I/R) of SP600125 treatment.

Conclusions: Our results demonstrate the important role the JNK pathway plays in retinal degeneration in both in vitro and in vivo models and suggest that JNK inhibitors may be a useful therapeutic strategy for neuroprotection of RGCs in the retina.

Citing Articles

The molecular mechanisms underlying retinal ganglion cell apoptosis and optic nerve regeneration in glaucoma (Review).

Wang X, Sun L, Han X, Li Z, Xing Y, Chen X Int J Mol Med. 2025; 55(4).

PMID: 39950327 PMC: 11878485. DOI: 10.3892/ijmm.2025.5504.

Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms.

Tang Q, Buonfiglio F, Bohm E, Zhang L, Pfeiffer N, Korb C Antioxidants (Basel). 2024; 13(5).

PMID: 38790699 PMC: 11117924. DOI: 10.3390/antiox13050594.

Modeling of Retina and Optic Nerve Ischemia-Reperfusion Injury through Hypoxia-Reoxygenation in Human Induced Pluripotent Stem Cell-Derived Retinal Ganglion Cells.

Yoshida T, Yokoi T, Tanaka T, Matsuzaka E, Saida Y, Nishina S Cells. 2024; 13(2).

PMID: 38247823 PMC: 10814087. DOI: 10.3390/cells13020130.

Oxidative stress in the eye and its role in the pathophysiology of ocular diseases.

Bohm E, Buonfiglio F, Voigt A, Bachmann P, Safi T, Pfeiffer N Redox Biol. 2023; 68:102967.

PMID: 38006824 PMC: 10701459. DOI: 10.1016/j.redox.2023.102967.

Keratin8 Deficiency Aggravates Retinal Ganglion Cell Damage Under Acute Ocular Hypertension.

Zhang C, Yu N, Qin Q, Wu X, Gu Y, Liu T Invest Ophthalmol Vis Sci. 2023; 64(12):1.

PMID: 37656477 PMC: 10479409. DOI: 10.1167/iovs.64.12.1.

References

Wu X, Li L, Zhang L, Wu J, Zhou Y, Zhou Y . Inhibition of thioredoxin-1 with siRNA exacerbates apoptosis by activating the ASK1-JNK/p38 pathway in brain of a stroke model rats. Brain Res. 2014; 1599:20-31. DOI: 10.1016/j.brainres.2014.12.033. View

Hofbauer A, Drager U . Depth segregation of retinal ganglion cells projecting to mouse superior colliculus. J Comp Neurol. 1985; 234(4):465-74. DOI: 10.1002/cne.902340405. View

Yang D, Kuan C, Whitmarsh A, Rincon M, Zheng T, Davis R . Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 1998; 389(6653):865-70. DOI: 10.1038/39899. View

Otori Y, Wei J, Barnstable C . Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 1998; 39(6):972-81. View

Le-Niculescu H, Bonfoco E, Kasuya Y, Claret F, Green D, Karin M . Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol. 1998; 19(1):751-63. PMC: 83932. DOI: 10.1128/MCB.19.1.751. View

Guan Q, Pei D, Zhang Q, Hao Z, Xu T, Zhang G . The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways. Brain Res. 2005; 1035(1):51-9. DOI: 10.1016/j.brainres.2004.11.050. View

Munemasa Y, Ohtani-Kaneko R, Kitaoka Y, Kuribayashi K, Isenoumi K, Kogo J . Contribution of mitogen-activated protein kinases to NMDA-induced neurotoxicity in the rat retina. Brain Res. 2005; 1044(2):227-40. DOI: 10.1016/j.brainres.2005.03.014. View

Gao Y, Signore A, Yin W, Cao G, Yin X, Sun F . Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab. 2005; 25(6):694-712. DOI: 10.1038/sj.jcbfm.9600062. View

Mizuno N, Kokubu H, Sato M, Nishimura A, Yamauchi J, Kurose H . G protein-coupled receptor signaling through Gq and JNK negatively regulates neural progenitor cell migration. Proc Natl Acad Sci U S A. 2005; 102(35):12365-70. PMC: 1194958. DOI: 10.1073/pnas.0506101102. View

10.

Mayor-Torroglosa S, de la Villa P, Rodriguez M, Lopez-Herrera M, Aviles-Trigueros M, Garcia-Aviles A . Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine. Invest Ophthalmol Vis Sci. 2005; 46(10):3825-35. DOI: 10.1167/iovs.05-0392. View

11.

Kwong J, Caprioli J . Expression of phosphorylated c-Jun N-terminal protein kinase (JNK) in experimental glaucoma in rats. Exp Eye Res. 2005; 82(4):576-82. DOI: 10.1016/j.exer.2005.08.017. View

12.

Shackelford D, Yeh R . Modulation of ERK and JNK activity by transient forebrain ischemia in rats. J Neurosci Res. 2006; 83(3):476-88. DOI: 10.1002/jnr.20747. View

13.

Shen H, Liu Z . JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med. 2006; 40(6):928-39. DOI: 10.1016/j.freeradbiomed.2005.10.056. View

14.

Hayashi T, Sakai K, Sasaki C, Zhang W, Warita H, Abe K . c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci Lett. 2000; 284(3):195-9. DOI: 10.1016/s0304-3940(00)01024-7. View

15.

Tournier C, Hess P, Yang D, Xu J, Turner T, Nimnual A . Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 2000; 288(5467):870-4. DOI: 10.1126/science.288.5467.870. View

16.

Sugino T, Nozaki K, Takagi Y, HATTORI I, Hashimoto N, Moriguchi T . Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J Neurosci. 2000; 20(12):4506-14. PMC: 6772465. View

17.

Tezel G, Wax M . Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci. 2000; 20(23):8693-700. PMC: 6773089. View

18.

Li X, Commane M, Jiang Z, Stark G . IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc Natl Acad Sci U S A. 2001; 98(8):4461-5. PMC: 31857. DOI: 10.1073/pnas.071054198. View

19.

Takeuchi O, Akira S . Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol. 2001; 1(4):625-35. DOI: 10.1016/s1567-5769(01)00010-8. View

20.

Barr R, Bogoyevitch M . The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol. 2001; 33(11):1047-63. DOI: 10.1016/s1357-2725(01)00093-0. View